Lixte partners with Moffitt for phase Ib/II study of LB-100 in low and intermediate-1 risk MDS Aug. 22, 2018
GNE-616: a promising non-opioid drug candidate for the treatment of Nav1.7-mediated pain Aug. 22, 2018
Ichor announces utilization of TriGrid delivery system in a phase I/IIb study of GX-188E vaccine Aug. 22, 2018
GNE-684: a potent inhibitor of RIPK1 for treating inflammatory diseases due to dysregulated NEMO Aug. 22, 2018
RSS